News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
712,119 Results
Type
Article (43450)
Company Profile (347)
Press Release (668322)
Section
Business (211991)
Career Advice (2164)
Deals (37032)
Drug Delivery (103)
Drug Development (83925)
Employer Resources (173)
FDA (16611)
Job Trends (15528)
News (359199)
Policy (34332)
Tag
Academia (2608)
Alliances (51696)
Alzheimer's disease (1254)
Approvals (16526)
Artificial intelligence (140)
Bankruptcy (368)
Best Places to Work (11734)
Biotechnology (221)
Breast cancer (119)
Cancer (1073)
Cardiovascular disease (93)
Career advice (1802)
Cell therapy (231)
Clinical research (66555)
Collaboration (381)
Compensation (193)
COVID-19 (2623)
Data (1055)
Diabetes (160)
Diagnostics (6248)
Drug pricing (96)
Earnings (86916)
Employer resources (152)
Events (113384)
Executive appointments (288)
FDA (17126)
Funding (339)
Gene therapy (184)
GLP-1 (643)
Government (4511)
Healthcare (18992)
Infectious disease (2711)
Inflammatory bowel disease (110)
Interviews (337)
IPO (16719)
Job creations (4156)
Job search strategy (1549)
Layoffs (449)
Legal (8461)
Lung cancer (174)
Manufacturing (184)
Medical device (13305)
Medtech (13310)
Mergers & acquisitions (20361)
Metabolic disorders (440)
Neuroscience (1526)
NextGen Class of 2024 (6714)
Non-profit (4538)
Northern California (1425)
Obesity (258)
Opinion (221)
Patents (105)
People (58683)
Pharmaceutical (101)
Phase I (20679)
Phase II (29248)
Phase III (21925)
Pipeline (445)
Postmarket research (2673)
Preclinical (8753)
Radiopharmaceuticals (243)
Rare diseases (221)
Real estate (6348)
Regulatory (22671)
Research institute (2381)
Resumes & cover letters (370)
Southern California (1269)
Startups (3778)
United States (13271)
Vaccines (578)
Weight loss (207)
Date
Last 7 days (932)
Last 30 days (3473)
Last 365 days (36343)
2024 (32949)
2023 (40928)
2022 (52113)
2021 (56676)
2020 (55112)
2019 (47824)
2018 (36141)
2017 (33571)
2016 (33169)
2015 (39008)
2014 (32960)
2013 (28077)
2012 (30165)
2011 (30871)
2010 (28889)
Location
Africa (804)
Arizona (199)
Asia (40925)
Australia (6489)
California (3223)
Canada (1264)
China (244)
Colorado (144)
Connecticut (147)
Europe (87546)
Florida (444)
Georgia (112)
Illinois (347)
Indiana (201)
Kansas (96)
Maryland (579)
Massachusetts (2574)
Michigan (154)
Minnesota (270)
New Jersey (938)
New York (931)
North Carolina (733)
Northern California (1425)
Ohio (136)
Pennsylvania (820)
South America (1179)
Southern California (1269)
Texas (448)
Washington State (360)
712,119 Results for "hookipa pharma inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
HOOKIPA Pharma’s Eseba-vec Highlighted in SITC Late-Breaker
November 12, 2024
·
6 min read
Pharm Country
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncology 2024 Annual Meeting
HOOKIPA Pharma Inc. today announced that members of HOOKIPA’s Executive Team will host an investor call on June 4, 2024, at 4:15 p.m. ET.
May 30, 2024
·
5 min read
Pharm Country
HOOKIPA Pharma to Host Investor Call on HB-200 and Planned Path to Registration
HOOKIPA Pharma Inc. announced that members of HOOKIPA’s Executive Team will host an investor call summarizing the Company’s constructive regulatory interactions with the U.S. Food & Drug Administration and the European Medicines Agency.
April 10, 2024
·
5 min read
Press Releases
HOOKIPA Pharma Reports Third Quarter 2024 Financial Results and Provides Recent Business Updates
November 15, 2024
·
12 min read
Pharm Country
HOOKIPA Pharma to Participate in Leerink Partners Global Biopharma Conference
HOOKIPA Pharma Inc. announced that HOOKIPA’s Chief Financial Officer, Reinhard Kandera, will present at the Leerink Partners Global Biopharma Conference on March 13, 2024.
March 6, 2024
·
3 min read
Business
HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
HOOKIPA Pharma Inc., a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, reported financial results and recent business highlights for the first quarter of 2024.
May 9, 2024
·
11 min read
Pharm Country
HOOKIPA Pharma Announces Positive Clinical Data to be Presented at the American Society for Clinical Oncology 2024 Annual Meeting
HOOKIPA Pharma Inc. announced positive updated results from its Phase 1/2 clinical trial of HB-200 for the treatment of human papillomavirus 16 positive head and neck cancers.
May 23, 2024
·
11 min read
Drug Development
HOOKIPA Pharma Announces Updated Phase 2 Clinical Data at the American Society of Clinical Oncology 2024 Annual Meeting
HOOKIPA Pharma Inc. today announced positive updated results from its Phase 2 clinical trial of HB-200 in combination with pembrolizumab in patients with recurrent/metastatic human papillomavirus 16 positive (HPV16+) head and neck cancer.
June 4, 2024
·
10 min read
Press Releases
HOOKIPA Pharma to Present Strong Preclinical HB-700 Dataset
September 24, 2024
·
5 min read
Press Releases
HOOKIPA Pharma to Present Eseba-vec Combo in Frontline HNSCC as a Late-Breaker Poster Presentation at SITC 2024
October 31, 2024
·
5 min read
1 of 71,212
Next
